Contact Us
Guest Entrance & Main Lobby
Genomic Health, Inc.
101 Galveston Drive
Redwood City, CA 94063-4700
Tel: +1 (650) 556-9300
Fax: +1 (650) 556-1132
General Mailing & Overnight Delivery Address
Genomic Health, Inc.
301 Penobscot Drive
Redwood City, CA 94063-4700
Tel: +1 (866) ONCOTYPE (866-662-6897)
Customer Service
United States
Physicians
Breast and Colon Cancer Assays
Tel: +1 (866) ONCOTYPE (866-662-6897)
Fax: +1 (866) 444-0640
Email: Customer Service
Prostate Cancer Assay
Tel: +1 (877) ONCOTYPE (877-662-6897)
Fax: +1 (650) 362-6487
Email: Customer Service
Patients
All Products:
Tel: +1 (888) ONCOTYPE (888-662-6897)
Email: Customer Service
Canada
Physicians
Breast and Colon Cancer Assays
Tel: +1 (866) ONCOTYPE (866-662-6897)
Fax: +1 (650) 569-2081
Email: International
Prostate Cancer Assay
Tel: +1 (877) ONCOTYPE (877-662-6897)
Fax: +1 (650) 569-2081
Email: International
Patients
All Products:
Tel: +1 (888) ONCOTYPE (888-662-6897)
Email: International
Puerto Rico
Physicians:
Breast and Colon Cancer Assays
Tel: +1 (866) ONCOTYPE (866-662-6897)
Fax: +1 (650) 556-1073
Email: Customer Service
Prostate Cancer Assay
Tel: +1 (877) ONCOTYPE (877-662-6897)
Fax: +1 (650) 556-1073
Email: Customer Service
Patients:
All Products
Tel: +1 (877)-444-9876
Email: Customer Service
Americas and Asia Pacific
All Products:
Tel: +1 650 569 2080
Fax: +1 650 569 2081
Email: International
Europe
Local phone numbers available:
http://www.oncotypedx.com/contact
Payments & Insurance Address
Oncotype DX test payment
Genomic Health, Inc.
PO Box 742415
Los Angeles, CA 90074-2415
GAP Reimbursement
Email: GAP Reimbursement
Patient Advocacy
Email: Advocacy
Careers
Opportunities at Genomic Health
Media Relations
Tel: +1 (650) 569-2215
Email: Media
Investor Relations
Tel: +1 (650) 569-2281
Email: Investors
Business Development
Email: Business Development
Intellectual Property
Email: Intellectual Property
Government & Regulatory Affairs
Email: Policy
Contracts/Licensing
Email: Contracts
General Legal
Email: Legal
Website Comments
Email: Webmaster.